Table 1 Comparison of antibiotic resistance rates in Nepal and Bangladesh
Antibiotic | Country (%) | ||
|---|---|---|---|
Nepal (n = 42) | Bangladesh (n = 56) | Both countries (n = 98) | |
Current Study | |||
 Garenoxacin1 | 12/42 (28.6) | 29/56 (51.8) | 41/98 (41.8) |
 Sitafloxacin | 2/42 (4.8) | 1/56 (1.8) | 3/98 (3.1) |
 Furazolidone | 0/42 (0.0) | 0/56 (0.0) | 0/98 (0.0) |
 Rifabutin | 0/42 (0.0) | 0/56 (0.0) | 0/98 (0.0) |
 Rifaximin | 22/42 (52.4) | 36/56 (64.3) | 58/98 (59.2) |
Previous Study2 | |||
 Clarithromycin | 9/42 (21.4) | 22/56 (39.3) | 31/98 (31.6) |
 Amoxicillin | 0/42 (0.0) | 2/56 (3.6) | 2/98 (2.0) |
 Metronidazole | 37/42 (88.1) | 53/56 (94.6) | 90/98 (91.8) |
 Tetracycline | 0/42 (0.0) | 0/56 (0.0) | 0/98 (0.0) |
 Levofloxacin | 18/42 (42.9) | 37/56 (66.1) | 55/98 (56.1) |